
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1052 | 989 | 1026 | 1320 | 1678 | 2570 |
Fund Return | 5.15% | -1.05% | 2.64% | 9.71% | 10.9% | 9.9% |
Place in category | 413 | 626 | 366 | 10 | 21 | 44 |
% in Category | 49 | 72 | 42 | 1 | 6 | 11 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
S Horizon Global Technology Fund Hg | 4.76M | 35.99 | 12.67 | 19.40 | ||
S Horizon Global Technology Fund Ag | 22.5M | -3.42 | 15.78 | 17.78 | ||
S Horizon Global Technology Fund 1g | 2.13M | -3.29 | 16.79 | 18.80 | ||
Opportunities Fund I Inc | 29.31M | 9.45 | 10.96 | 8.74 | ||
Opportunities Fund P Acc | 443.58K | 9.48 | 11.27 | 9.05 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Wellington Global Health Care EquiG | 1.86B | 6.70 | 4.03 | 11.14 | ||
Adamant Medtech I GBP | 1.53B | 7.47 | 6.21 | 12.34 | ||
Global Health Care Fund W Acc GBP | 100.74M | 7.87 | 5.51 | 9.11 | ||
Pharmaceuticals Index Trust R Dist | 112.83K | 2.80 | 1.61 | 8.80 | ||
Pharmaceuticals Index Trust I Acc | 484.69M | 3.24 | 1.99 | 9.39 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 10.10 | 822.51 | +0.10% | |
UnitedHealth | US91324P1021 | 5.98 | 516.04 | +0.06% | |
AstraZeneca | GB0009895292 | 3.99 | 11,416.0 | +1.96% | |
Novo Nordisk B | DK0062498333 | 3.39 | 474.1 | -1.37% | |
J&J | US4781601046 | 3.30 | 163.71 | +0.36% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review